Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

03 July 2024 : Clinical Research  

Cystatin SN (CST1) Is a Poor Independent Prognostic Biomarker for Gastrointestinal Diffuse Large B-Cell Lymphoma

Jie Wang1ABCDEFG*, Ming Yang2CD, Sheng Chen2CEF, Hongbo Zhu1AB, Zhirong Zhang1CD

DOI: 10.12659/MSM.943551

Med Sci Monit 2024; 30:e943551

Figure 1 The expression of CST1 in GI-DLBCL(A) The expressions of CST1 in 84 cases of GI-DLBCL were detected with immunohistochemistry (IHC). The patients were classified into subgroups with low and high expression of CST1. The IHC scores of representative images of left and right panel is 0 and 9 respectively. (B) The expressions of CST1 in 7 cases of GI-DLBCL tissues and adjacent GI tissues were detected with RT-qPCR. The statistical significance was analyzed by compared t test. Graphpad Prism 5 and Adobe Illustrator CS5 were used to generate this figure.

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750